BD (Becton, Dickinson and Company), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton ...
Represents costs recorded to Other operating expense, net incurred in connection with the separation of BD's former Diabetes Care business.
- Revenue Adjustment Impact reflects the recognition of accruals resulting from developments relating to the Italian government medical device pay back legislation, as well as another legal matter ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm notes shares have struggled mightily the past 6 ...